Ectonucleotidases and purinergic receptors in mouse prostate gland Publication: Bill Yu, J., C. Sharkey, A. F. Olumi, and Z. Wang. 2025. Ectonucleotidases and Purinergic Receptors in Mouse Prostate Gland.
Effect of TNF-α Inhibitor Therapy on Growth of the Prostate Gland Publication: Bill Al-Faouri, R., C. Sharkey, B. Gershman, L. L. Tsai, Z. Wang, and A. F. Olumi. 2024. Effect of TNF-α Inhibitor Therapy on Growth of the Prostate Gland.
Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder Publication: Bill Mao, W., T. Zhang, H. Chen, S. Barge, Z. Wang, A. Olumi, S. Alper, and W. Yu. 2025. Expression and Distribution of Activin-Follistatin-Inhibin Axis in the Urinary Bladder.
Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy Publication: Bill Schaufler, C., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. Kim, et al. 2024. Immediate Radiotherapy versus Observation in Patients With Node-Positive Prostate Cancer After Radical Prostatectomy.
Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts Publication: Bill San Francisco, I. F., W. C. DeWolf, D. M. Peehl, and A. F. Olumi. 2004. Expression of Transforming Growth Factor-Beta 1 and Growth in Soft Agar Differentiate Prostate Carcinoma-Associated Fibroblasts from Normal Prostate Fibroblasts.
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations Publication: Bill Li, L., L. Zhang, X. Zhang, Q. Yan, Y. A. Minamishima, A. F. Olumi, M. Mao, S. Bartz, and W. G. Kaelin Jr. 2007. Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen With Type 2A and Type 2B VHL Mutations.
Stromally expressed c-Jun regulates proliferation of prostate epithelial cells Publication: Bill Li, W., C. L. Wu, P. G. Febbo, and A. F. Olumi. 2007. Stromally Expressed C-Jun Regulates Proliferation of Prostate Epithelial Cells.
MR imaging of renal masses: correlation with findings at surgery and pathologic analysis Publication: Bill Pedrosa, I., M. R. Sun, M. Spencer, E. M. Genega, A. F. Olumi, W. C. Dewolf, and N. M. Rofsky. 2008. MR Imaging of Renal Masses: Correlation With Findings at Surgery and Pathologic Analysis.
Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system Publication: Bill Dong, F., C. Wang, A. B. Farris, S. Wu, H. Lee, A. F. Olumi, W. S. McDougal, R. H. Young, and C. L. Wu. 2012. Impact on the Clinical Outcome of Prostate Cancer by the 2005 International Society of Urological Pathology Modified Gleason Grading System.
5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer Publication: Bill Preston, M. A., K. M. Wilson, S. C. Markt, R. Ge, C. Morash, M. J. Stampfer, M. Loda, E. Giovannucci, L. A. Mucci, and A. F. Olumi. 2014. 5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.